Cetera Advisor Networks LLC Alkermes Plc. Transaction History

Cetera Advisor Networks LLC

  • $0
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$27.17 - $31.97 $18,122 - $21,323
-667 Reduced 7.8%
7,886 $220,000
Q2 2023

Aug 09, 2023
BUY
$28.34 - $33.63 $20,829 - $24,718
735 Added 9.4%
8,553 $267,000
Q1 2023

May 15, 2023
SELL
$25.31 - $29.02 $379 - $435
-15 Reduced 0.19%
7,818 $220,000
Q4 2022

Feb 14, 2023
BUY
$21.94 - $26.24 $171,856 - $205,537
7,833 New
7,833 $204,000
Q2 2022

Aug 11, 2022
BUY
$26.4 - $30.54 $182,160 - $210,726
6,900 New
6,900 $206,000

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email